The penalty is a new power allowed by the Inflation Reduction Act, which became law in August 2022. The federal government is working to quell the rise of drug prices by fining drugmakers with cost increases that outpace the rate of inflation. In March, the White House listed 27 Medicare Part B medications subject to penalties.
The 48 drugs that are facing enforced rebates in January are between $1 and $2,786 per dose, the White House said in a Dec. 14 news release. Sixteen other therapies could be added to the fray.
Access the list of 48 drugs here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
